Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Change in Receivables: 2011-2019

Historic Change in Receivables for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Dec 2019 value amounting to $12.5 million.

  • EyePoint Pharmaceuticals' Change in Receivables rose 21366.10% to $12.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $15.1 million, marking a year-over-year increase of 1469.06%. This contributed to the annual value of $244,000 for FY2024, which is 101.69% up from last year.
  • EyePoint Pharmaceuticals' Change in Receivables amounted to $12.5 million in Q4 2019, which was up 513.25% from $2.0 million recorded in Q1 2019.
  • In the past 5 years, EyePoint Pharmaceuticals' Change in Receivables registered a high of $12.5 million during Q4 2019, and its lowest value of -$384,000 during Q4 2015.
  • In the last 3 years, EyePoint Pharmaceuticals' Change in Receivables had a median value of $164,000 in 2017 and averaged $1.5 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first tumbled by 1,512.50% in 2017, then skyrocketed by 21,366.10% in 2019.
  • EyePoint Pharmaceuticals' Change in Receivables (Quarterly) stood at -$384,000 in 2015, then surged by 113.54% to $52,000 in 2016, then increased by 5.77% to $55,000 in 2017, then crashed by 207.27% to -$59,000 in 2018, then soared by 21,366.10% to $12.5 million in 2019.
  • Its Change in Receivables was $12.5 million in Q4 2019, compared to $2.0 million in Q1 2019 and -$59,000 in Q4 2018.